Clinical Trials Sponsored by GNT Pharma
Total 8558 results
-
Zealand PharmaCompletedRenal ImpairmentHungary, Poland
-
LEO PharmaCompletedAtopic DermatitisUnited States, France, Netherlands
-
LEO PharmaCompletedPsoriasis VulgarisUnited States, United Kingdom, Canada, Germany
-
UCB PharmaCompletedEpilepsy, PartialUnited States, France, United Kingdom, Germany, Belgium, Mexico, Poland, Romania, Canada, Brazil, Russian Federation, Argentina, Hungary, Italy, Czechia
-
MaaT PharmaCompletedLeukemia, Myeloid, AcuteFrance
-
UCB PharmaCompletedCrohn's DiseaseJapan
-
UCB PharmaCompletedSeasonal Allergic RhinitisUnited States
-
Evoke PharmaCompletedDiabetic GastroparesisUnited States
-
Evoke PharmaCompletedDiabetic GastroparesisUnited States
-
LEO PharmaTerminatedAtopic DermatitisUnited States, Netherlands, United Kingdom, France, Canada, Ireland, Austria, Germany, Poland
-
LEO PharmaCompleted
-
LEO PharmaCompletedActinic KeratosisNetherlands
-
LEO PharmaCompleted
-
LEO PharmaCompletedSecondary HyperparathyroidismGermany, Poland
-
LEO PharmaWithdrawn
-
LEO PharmaWithdrawnAtopic DermatitisNetherlands
-
LEO PharmaTerminated
-
UCB PharmaCompletedEpilepsyUnited States, France, Hungary, Mexico, Poland
-
LEO PharmaCompleted
-
LEO PharmaCompletedPsoriasis VulgarisFrance
-
LEO PharmaCompletedDeep Vein ThrombosisBulgaria, Croatia, Czechia, France, Germany, Poland, Romania, Serbia, Spain
-
MaaT PharmaTerminatedIntensive Care Units | Fecal Microbiota TransplantationFrance
-
Iltoo PharmaCompletedSystemic Lupus ErythematosusFrance, Spain, Mexico, Austria, Germany, Bulgaria, Italy, Mauritius, Portugal, Romania
-
LEO PharmaCompletedAcne VulgarisUnited States
-
LEO PharmaCompletedActinic KeratosisCanada, United States
-
LEO PharmaCompleted
-
LEO PharmaCompletedActinic KeratosisUnited States
-
LEO PharmaCompletedActinic KeratosisUnited States
-
LEO PharmaCompleted
-
LEO PharmaCompletedPsoriasis VulgarisUnited States, Canada, United Kingdom, Germany, Romania, France, Poland
-
UCB PharmaCompletedEpilepsyUnited States, Mexico, India, Brazil
-
LEO PharmaCompletedPlaque Psoriasis | Psoriasis VulgarisGermany
-
UCB PharmaCompleted
-
LEO PharmaCompletedSecondarily Infected Traumatic Lesions | ImpetigoUnited States, South Africa
-
UCB PharmaTerminatedCrohn's DiseaseUnited States, Germany, Canada
-
UCB PharmaCompletedCrohn DiseaseUnited States, Australia, Italy, Ukraine, Germany, Belgium, Israel, Romania, Canada, New Zealand, Brazil, Estonia, Russian Federation, Chile, Austria, Poland, Hungary, Latvia, Czechia, Finland
-
UCB PharmaCompletedCrohn's DiseaseUnited States, France, Italy, United Kingdom, Belgium, Germany, Spain, Switzerland, Canada, Netherlands, Austria, Sweden
-
UCB PharmaCompletedCrohn's DiseaseUnited States, France, Italy, United Kingdom, Belgium, Germany, Spain, Switzerland, Canada, Netherlands, Denmark, Austria, Norway, Sweden
-
Dermis PharmaCompleted
-
UCB PharmaCompletedRheumatoid ArthritisUnited States, France, Canada
-
UCB PharmaCompletedOpen Label Long-Term Safety Study of Certolizumab Pegol (CZP) for Patients With Rheumatoid ArthritisRheumatoid ArthritisUnited States, United Kingdom, Belgium, Germany, Austria, Ireland, Czechia
-
UCB PharmaCompletedRheumatoid ArthritisUnited States, France, Italy, Germany, Spain, Canada, Netherlands
-
UCB PharmaCompletedRheumatoid ArthritisUnited States, Canada
-
UCB PharmaCompletedRheumatoid ArthritisGermany, United States, Argentina, Australia, Austria, Belgium, Canada, Colombia, Czechia, France, Hungary, Ireland, Italy, Mexico, Monaco, Netherlands, Poland, Romania, Spain, Sweden, Switzerland, United Kingdom
-
UCB PharmaCompletedFibromyalgia SyndromeUnited States
-
UCB PharmaCompleted
-
UCB PharmaCompletedEpilepsyUnited States, Czechia, Germany, Poland
-
LEO PharmaTerminated